Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
Overview
The purpose of this study is to to compare two bowel preparation regimens of patients who will undergo colonoscopy, in terms of quality of bowel preparation and in terms of patient satisfaction.
Full Title of Study: “PRECOL2011-1: Sodium Picophosphate and Magnesium Citrate Versus Polyethylene Glycol as Evacuating Treatment Prior to Colonoscopy: Phase IV Randomized Trial.”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: December 2024
Interventions
- Drug: polyethylene glycole (PEG) solution
- Drug: sodium picosulphate and magnesium citrate solution
Arms, Groups and Cohorts
- Active Comparator: PEG
- polyethylene glycol solution 2 liters
- Active Comparator: NapP
- Sodium picosulphate and magnesium citrate solution 300 ml
Clinical Trial Outcome Measures
Primary Measures
- Boston Bowel Preparation Scale value
- Time Frame: at time of colonscopy
- evaluated by two endoscopists who are blinded to treatment assigned at randomization
- patient reported acceptability score
- Time Frame: just prior to colonscopy
- using visual analog scale
Secondary Measures
- percent of bowel cleansing regimen dose assumed as reported by patient
- Time Frame: just prior to colonoscopy
Participating in This Clinical Trial
Inclusion Criteria
• Subjects who are candidate to undergo colonoscopy: Diagnosis Screening Follow-up after previous polypectomy
- Informed consent – Age > 18 years Exclusion Criteria:
- Previous colonic resection – Severe inflammatory bowel disease (IBD)
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- National Cancer Institute, Naples
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Valentina D’Angelo, M.D., Principal Investigator, National Cancer Institute, Naples
- Mario de Bellis, M.D., Principal Investigator, National Cancer Institute, Naples
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.